SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-23-063202
Filing Date
2023-05-22
Accepted
2023-05-22 16:53:13
Documents
13
Period of Report
2023-05-22
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2316465d1_8k.htm   iXBRL 8-K 26869
2 EXHIBIT 99.1 tm2316465d1_ex99-1.htm EX-99.1 34022
  Complete submission text file 0001104659-23-063202.txt   244850

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA bpmc-20230522.xsd EX-101.SCH 3063
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE bpmc-20230522_lab.xml EX-101.LAB 34476
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE bpmc-20230522_pre.xml EX-101.PRE 22615
7 EXTRACTED XBRL INSTANCE DOCUMENT tm2316465d1_8k_htm.xml XML 3495
Mailing Address 45 SIDNEY STREET CAMBRIDGE MA 02139
Business Address 45 SIDNEY STREET CAMBRIDGE MA 02139 617-374-7580
Blueprint Medicines Corp (Filer) CIK: 0001597264 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37359 | Film No.: 23945282
SIC: 2834 Pharmaceutical Preparations